NRGN and Alzheimer disease: Neurogranin (NRGN) is a promising fluid biomarker for synaptic damage, showing both high CSF levels in AD and correlation with cognitive decline [10–14], as well as correlation with hippocampal volume and brain metabolic activity measured by FDG PET [11].